Share
Scientific Abstracts
Oral Presentations
Abstract Session: Early pathogenic mechanisms; clues for targeted therapies in arthritis
OP0088 Discovery of a novel anti-bone resorption compound, AS2690168, which inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand (RANKL)